Physician profile
John P Belzer
NPI 1417043993
$6,668.86
in general payments reported to CMS, 2019-2025
17 companies · $2,726 in 2025
The $2,726 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $34.39 · 2021: $203 · 2022: $14.45 · 2023: $3,025 · 2024: $518 · 2025: $2,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,857 · Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,857.01 |
| Food and Beverage | $2,411.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,525.09 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Mako |
| Miach Orthopaedics, INC. | $2,188.77 | 2023-2025 | |
| Smith+Nephew, INC. | $343.59 | 2020-2024 | Journey II, Ri Hip Navigation, Real Intelligence |
| Evolution Surgical, INC | $154.66 | 2025 | |
| The Cameron-Ehlen Group, INC. | $135.60 | 2019 | |
| Arthrex, INC. | $67.57 | 2024 | Capital Consumables Consumables Insufflation |
| Pacira Pharmaceuticals Incorporated | $50.87 | 2021-2025 | Exparel |
| Bioventus LLC | $28.97 | 2025 | Durolane |
| Vertex Pharmaceuticals Incorporated | $27.82 | 2025 | |
| Pacira Therapeutics, INC. | $26.34 | 2021 | |
| Avanos Medical | $24.20 | 2021 | |
| Davol INC. | $23.63 | 2025 | Arista |
| Heron Therapeutics, INC. | $18.95 | 2021 | |
| Depuy Synthes Sales INC. | $16.64 | 2021 | |
| Baudax Bio INC. | $14.45 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $12.35 | 2019 | |
| Heraeus Medical, LLC. | $9.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Belzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.